To further test our hypothesis that resistance to BRAFi may be mediated through SRC as a common signal transduction node, we modulated the expression of SRC and assessed the response of BRAFV600E CRC to specific BRAFi. This evidence concerns the gene SRC and colorectal carcinoma.